Otezla is a branded oral prescription medicine presented as a treatment option for adults with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease. The website introduces Otezla as a pill and directs visitors to its full prescribing information and safety information, helping patients and healthcare professionals review important details about its use. The brand’s online presence centers on explaining the conditions for which Otezla is indicated and providing access to medication-related information.

Visitors can also manage cookie and privacy preferences on the site. Its notice explains that Amgen may use cookies and similar technologies to personalize content and advertising, support social media features, and collect website usage information; it also offers controls for consent and preferences. Otezla is therefore presented primarily as a treatment brand, with its website serving as a source of product and safety information rather than a broader range of products or services.

The site emphasizes that users should consult the official prescribing and safety materials for complete information